biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by fatboy92on Aug 14, 2015 1:20pm

155 Views

Post# 24019197

RE:RE:RE:RE:JD

Moaning and complaining about the share price can't possibly be helping your investment at all. I'm sure your and Dr J's words have put doubt in many possible investors who have come by our forum to check out the sentiment of shareholders. Your alias oilpatch could never figure that out and you can't. Your constant posting is driving people away from this board. Turning the words of those posters who have great insight, information and opinions into some long lost discussions in order to combat your incessant chronic words of displeasure and disappointment. Your next alias should be clueless because that would more explain your mentality. Back to patiently enjoying my summer.

Bullboard Posts

Unique Battery Metals opportunity in Quebec